Drawing for ADLANTIS

USPTO serial 76353324

ADLANTIS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MANDIR, FREDERICK
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ADLANTIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James D. Withers

JAMES D WITHERS MERCHANT & GOULD PCP O BOX 2910MINNEAPOLIS, MN 55402-0919UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment, prophylaxis and diagnosis of human diseases and illnesses and veterinary preparations for the treatment, prophylaxis and diagnosis of diseases and conditions of livestock and pets; vaccines; diagnostic preparations and chemical reagents for clinical medical laboratory use; diagnostic preparations and chemical reagents for veterinary purposes in the treatment of diseases and conditions in livestock and petsACTIVE—
042Scientific and industrial research, in particular in the medical and pharmaceutical fields; scientific research, namely, conducting scientific searches; consultation services, namely, giving technical opinions in the field of medicine and pharmaceutical; providing the services of a biologist, biochemist, chemist, doctor, pharmacist, psychologist, and psychotherapist; providing an online computer database in the field of pharmaceutical and veterinary preparations; computer software development and design for others; computer programming for others, namely, creating computer software, all exclusive of services rendered to advertising agenciesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Mar 1, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 15, 2003CNSIINQUIRY AS TO SUSPENSION MAILED—
Dec 6, 2002CNSLLETTER OF SUSPENSION MAILED—
Sep 30, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 30, 2002MAILPAPER RECEIVED—
Mar 28, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance